overall survival
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
overall survival
Jun 24, 2024, 23:11 |
Blog
Chandler Park: Superb discussion of the TRANSMET study presented at ASCO24 by Cathy Eng
Chandler Park shared on X: “Dr. Cathy Eng provides a superb and thoughtful discussion of…
Jun 22, 2024, 05:04 |
Blog
Yüksel Ürün: Carboplatin plus docataxel for patients with biallelic HRR gene alterations in metastatic castration-resistant prostate cancer
Yüksel Ürün shared a post on X: “The ABCD Trial shows promising results with carboplatin…
Jun 21, 2024, 06:47 |
Insight
Filippo Montemurro: Not all pCR are made equal
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Impact…
Jun 19, 2024, 03:11 |
Insight
Andres Rodriguez Mignola: SBRT in Oligometastatic Disease in Gynecologic Tumors - A Therapeutic Option?
Andres Rodriguez Mignola, Radiation Oncologist at Ángel Roffo Institute of Oncology, shared a post on…
Jun 15, 2024, 13:48 |
Insight
Myeloma Paper of the Day, June 15th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Natural killer cells with adhesion…
Jun 10, 2024, 15:00 |
Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 10:31 |
Opinion
Armando Orlandi: To explain the unexplainable in MONARCH 3
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:…
Jun 7, 2024, 13:10 |
Opinion
Paolo Tarantino: Among the ASCO24 abstracts, particularly notable was the DB03 update
Erika Hamilton shared Paolo Tarantino's post on X, adding: , "Agree, I…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 4, 2024, 04:06 |
Blog
Jun Gong: Dr. Martijn Meijerink's Phase III COLLISION trial less than 10 colorectal liver metastases
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post…
1
2
All:
20
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube